The FDA recommends that patients due to start treatment with Veopoz be vaccinated at least two weeks beforehand. The approval also puts Regeneron in line for a valuable priority review voucher ...
In a late-stage, head-to-head trial against Alexion Pharmaceuticals’ standard-of-care medicine Ultomiris, Regeneron showed that its combination of the antibody Veopoz with an investigative siRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback